Skip to main content
Clinical Trials/CTRI/2017/10/010066
CTRI/2017/10/010066
Recruiting
Phase 2

An open label single arm clinical study on the combined effectiveness of Chitrakadi Vati and Avipathi Churnam in the management of Hypothyroidism

Dr Anoop A S0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Health Condition 1: null- Hypothyroidism
Sponsor
Dr Anoop A S
Status
Recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Dr Anoop A S

Eligibility Criteria

Inclusion Criteria

  • Diagnosis will be made on the basis of TSH value more than 15\-20 mU/l which may or may not be associated with decrease in T3 and T4 concentration and also with the signs and symptoms of Hypothyroidism one or multiplicity of these viz
  • 1\.tiredness,
  • 2\.dryness of skin,
  • 3\.feeling cold
  • 4\.hair loss,
  • 5\.constipation,
  • 6\.Weight gain with poor appetite
  • 7\.Hoarseness of voice,
  • 8\.muscle ache or stiffness,
  • 9\.menstrual disturbances,

Exclusion Criteria

  • Exclusion criteria are as follows
  • 1\.Patients who have undergone any type of thyroid surgery,
  • 2\.Patients suffering from systemic diseases like Ischemic Heart Disease, Diabetes mellitus, carcinomas,
  • 3\.Patients suffering from congenital hypothyroidism,
  • 4\.Pregnancy and lactation,
  • 5\.Rapid progressive case of myxedema,
  • 6\.Hypothyroidism due to drug therapy (e.g. Amiodarone, Lithium, Interferon)
  • 7\.Hypothyroidism due to infiltrative diseases like Sarcoidosis,Scleroderma and Haemochromatosis

Outcomes

Primary Outcomes

Not specified

Similar Trials